NGRI Clinical Context

The treatment goal for NGRI individuals is to mitigate their risk of harm to themselves or others so they can be reintegrated into the community. The key treatment areas include:

• Symptom stabilization

• Risk assessment and mitigation 

• Individualized treatment to develop strategies to address risk factors

• Continued care planning  

Back to top

The treatment team works with the individual to select and adjust medications (e.g., antipsychotics, mood stabilizers) that help reduce symptoms that impair insight while minimizing other risk factors.

The individual is supported in maintaining consistent medication intake through education, supervision, and motivational strategies designed to promote psychiatric stability and support risk reduction. 

Back to top

A medication petition is generally appropriate when a person with serious mental illness is refusing psychiatric medication, lacks the ability to make informed treatment decisions, and their untreated symptoms are significantly impairing their safety, functioning, or ability to participate in legal proceedings.

Procedures to pursue a medication petition include:

• Clinical Team Identification: Treating clinicians determine that the individual is refusing recommended psychiatric medication, lacks the capacity to make a reasoned treatment decision, and meets statutory criteria for medication over objection. 
• Clinical Evaluation & Documentation: The treating psychiatrist and treatment team document the person’s symptoms, treatment history, risks of non-treatment, alternatives attempted, and rationale for the proposed medication plan. 
• Petition Preparation: The hospital or treatment facility prepares a formal petition for involuntary treatment under the Illinois Mental Health and Developmental Disabilities Code 405 ILCS 5/2-107.1. 
• State’s Attorney Involvement: The State’s Attorney’s Office reviews and files the petition with the court and represents the State at the hearing. 
• Appointment of Defense Counsel: The individual is represented by counsel, typically a Guardianship and Advocacy Commission attorney (GAC) or an Assistant Public Defender (APD), who protects the respondent’s legal rights and may challenge the petition. 
• Scheduling of Hearing: Illinois law generally requires the hearing to occur within 7 days of filing the petition, excluding weekends, and holidays, unless continued for good cause. 
• Court Hearing: The treating clinician testifies regarding diagnosis, capacity, clinical deterioration, risks and benefits, and medication recommendations. Defense counsel may cross-examine witnesses, present evidence, or argue against involuntary treatment. 
• Judicial Determination: The judge determines whether the statutory criteria for medication over objection have been proven by clear and convincing evidence. 
• Court Order: If granted, the judge issues a time-limited order authorizing involuntary medication, typically for up to 90 days, after which a new petition is required if continued treatment over objection is sought.

Back to top

Forensic treatment for NGRI focuses on individuals developing insight into the factors that influence their risk of violence and how they can be successful in community-based recovery. Three aspects of risk are typically assessed:

• Historical Risk: What factors led to the index offense?
• Clinical Risk: How is the individual progressing in recovery? How stable is that recovery?
• Future Risk: What environmental factors will support the individual in maintaining stability in a less restrictive setting?

Privileges are also an essential tool to assess and mitigate risk in an inpatient setting. Privileges allow the team to observe the individual’s stability in increasingly less restrictive settings, mitigating risks by ensuring they can handle increasing level of freedom. Some of these include:

• Building passes: These are managed entirely at the clinical discretion of the treatment team without requiring a court order.
• Court approved privileges: Supervised on-grounds, unsupervised on-grounds, supervised off-grounds, and unsupervised off grounds passes allows the team to continue to monitor stability in new settings.

Even when a court has ordered privileges, the treatment team maintains the authority to restrict them based on their clinical discretion if risk increases. For principles guiding privileges, see Pathway 3: Secure Inpatient Treatment.

Back to top

Treatment and the timeline for community reintegration for forensic individuals is individualized, primarily through the assessment of personal progress, the development of tailored plans, and selection of appropriate levels of care based on specific needs.

Back to top

Continued care planning focuses on finding a community placement for individuals transitioning from inpatient treatment to outpatient treatment under conditional release or discharge. Continued care planning is vital for a successful transition to the community. By addressing potential barriers early (initiating Medicaid redetermination, applying for Social Security benefits 8–10 months in advance, etc.), treatment teams prevent administrative delays that could keep a stabilized individual in a more restrictive setting longer than necessary. This leads to a tailored aftercare and risk management plan which identifies the specific level of structure and supervision required to mitigate an individual’s unique risk factors and reduce the likelihood of them deteriorating once they leave the hospital. 

Back to top

Behavioral health care options range in level of restriction with the least restrictive being outpatient services and independent living while the most restrictive is a secure inpatient hospital with monitored programming.

Back to top